Stoilov Ivaylo R, Costa Vital P, Vasconcellos Jose P C, Melo Monica B, Betinjane Alberto J, Carani Jose C E, Oltrogge Ernst V, Sarfarazi Mansoor
Molecular Ophthalmic Genetics Laboratory, Surgical Research Center, Department of Surgery, University of Connecticut Health Center, Farmington, Connecticut CT 06030-1110, USA.
Invest Ophthalmol Vis Sci. 2002 Jun;43(6):1820-7.
To determine the distribution of CYP1B1 gene mutations in Brazilian patients with primary congenital glaucoma (PCG).
PCG diagnosis was established by presence of buphthalmos in at least one affected eye and associated high intraocular pressures before the age of 3 years. CYP1B1 mutation screening of 52 patients with PCG was performed by SSCP and direct sequencing of PCR fragments.
Eleven mutations, four of which are novel, were observed in 26 (50%) individuals. A new frameshift mutation (4340delG) was observed in 20.2% of all individuals screened. These individuals had early-onset, bilateral glaucoma that necessitated multiple surgical interventions. CYP1B1 mutations were twice as frequent in affected individuals of European descent as in individuals of African descent. Analysis of six intragenic single nucleotide polymorphisms (SNPs) established 5'-C-C-G-G-T-A-3' as the most common haplotype among the affected Brazilian individuals. A nonsense mutation (W57X) previously reported in an individual with Peters anomaly (compound heterozygote) was also observed in two individuals with PCG but combined with different mutations. A newly developed SSCP assay enabled us to detect all DNA mutations and polymorphisms previously detected by direct sequencing.
Our results indicate that CYP1B1 mutations may be responsible for half of cases of PCG in the Brazilian population. The SNP haplotype 5'-C-C-G-G-T-A-3' was associated with the majority of CYP1B1 mutations. This haplotype harbors the high-activity V432 allele, which is emerging as a putative susceptibility factor in several cancers.
确定巴西原发性先天性青光眼(PCG)患者中CYP1B1基因突变的分布情况。
通过至少一只患眼存在牛眼以及3岁前伴有高眼压来确诊PCG。对52例PCG患者进行CYP1B1突变筛查,采用单链构象多态性(SSCP)和PCR片段直接测序法。
在26例(50%)个体中观察到11种突变,其中4种为新突变。在所有筛查个体中,20.2%的个体存在一种新的移码突变(4340delG)。这些个体患有早发性双侧青光眼,需要多次手术干预。欧洲裔受累个体中CYP1B1突变的频率是非洲裔个体的两倍。对6个基因内单核苷酸多态性(SNP)的分析确定5'-C-C-G-G-T-A-3'为巴西受累个体中最常见的单倍型。在两名PCG患者中还观察到先前在一名彼得斯异常患者(复合杂合子)中报道的无义突变(W57X),但与不同突变组合。一种新开发的SSCP检测方法使我们能够检测到先前通过直接测序检测到的所有DNA突变和多态性。
我们的结果表明,CYP1B1突变可能是巴西人群中一半PCG病例的病因。SNP单倍型5'-C-C-G-G-T-A-3'与大多数CYP1B1突变相关。这种单倍型包含高活性V432等位基因,该等位基因在几种癌症中已成为一种假定的易感因素。